doi: 10.2147/DDDT.S524718 148 LaganASVitaglianoANoventaMAmbrosiniGDAnnaR
Serious adverse events were defined according to the European Medicines Agency (EMA) criteria ( 3 Discussion Eighty-two participants, who continued with 14 mg oral semaglutide (the highest dose registered for managing type 2 diabetes) for one year experienced a significant average weight loss of 5.7% (5.9 kg), along with a reduction in BMI by an average of 2 kg/m
Stay hydrated and eat mindfully
A cause-effect relationship with ethylene oxide exposure was demonstrated by haptan specificity (Dolovich & Bell, 1978)
GLP-1 Safety in Autoimmune Disease: What Research Shows Clinical evidence on GLP-1 use in active lupus remains limited, which is why physician oversight is essential
Step therapy that requires members to fail before accessing the right therapy, formulary exclusions that protect rebate-generating drugs and prior authorization applied broadly to avoid cost rather than ensure appropriate use all create the same problem: members pay the price